A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study-Reference-Cited by-同舟云学术

A phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or persistent ovarian cancer: a Gynecologic Oncology Group partners study

Published:2017-05 Issue:5 Volume:28 Page:996-1004
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Monk B.J.,Brady M.F.,Aghajanian C.,Lankes H.A.,Rizack T.,Leach J.,Fowler J.M.,Higgins R.,Hanjani P.,Morgan M.,Edwards R.,Bradley W.,Kolevska T.,Foukas P.,Swisher E.M.,Anderson K.S.,Gottardo R.,Bryan J.K.,Newkirk M.,Manjarrez K.L.,Mannel R.S.,Hershberg R.M.,Coukos G.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/28/5/996/24169403/mdx049.pdf

Reference28 articles.

1. American Cancer Society. What are the key statistics about ovarian cancer? [article on internet] 2016. https://www.cancer.org/cancer/ovarian-cancer/about/key-statistics.html (22 September 2016, date last accessed).

2. NIH National Cancer Institute. SEER Stat Fact Sheets: Ovarian Cancer [database on internet] 2016. https://seer.cancer.gov/statfacts/html/ovary.html (9 November 2016, date last accessed).

3. Latest research and treatment of advanced-stage epithelial ovarian cancer;Coleman;Nat Rev Clin Oncol,2013

4. Ovarian cancer, Version 1.2016, NCCN clinical practice guidelines in oncology;Morgan;J Natl Compr Canc Netw,2016

5. Randomised controlled trial comparing single agent paclitaxel vs epidoxorubicin plus paclitaxel in patients with advanced ovarian cancer in early progression after platinum-based chemotherapy: an Italian Collaborative Study from the ‘Mario Negri’ Institute, Milan, G.O.N.O. (Gruppo Oncologico Nord Ovest) group and I.O.R. (Istituto Oncologico Romagnolo) group

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liposomes-enabled cancer chemoimmunotherapy;Biomaterials;2025-02

2. Fractionated photoimmunotherapy stimulates an anti-tumour immune response: an integrated mathematical and in vitro study;British Journal of Cancer;2024-09-11

3. T cell exhaustion and senescence for ovarian cancer immunotherapy;Seminars in Cancer Biology;2024-09

4. Post Natal Microbial and Metabolite Transmission: The Path from Mother to Infant;Nutrients;2024-06-22

5. When will the immune-stimulating antibody conjugates (ISACs) be transferred from bench to bedside?;Pharmacological Research;2024-05